Earnings Preview: ASND to Report Financial Results Post-market on November 14

$Ascendis Pharma A/S(ASND.US)$ is scheduled to release its financial results post-market on November 14 ET. Earnings PreviewAnalysts estimate $Ascendis Pharma A/S(ASND.US)$ to post revenue of EUR70.31

Futu NewsNov 9 09:00

Ascendis Pharma to Report Third Quarter 2024 Financial Results and Provide Business Update on November 14, 2024

GlobeNewswireNov 8 05:01

Novo Nordisk Q3 Preview: Will $285 Million Weight Loss Bet Offset Bearish Charts?

BenzingaNov 5 23:00

A Quick Look at Today's Ratings for Ascendis Pharma A/S(ASND.US), With a Forecast Between $167 to $289

Futu NewsNov 5 21:00 · Ratings

Express News | Ascendis Pharma A/S : Wedbush Assumes Coverage With Outperform Rating; Target Price $181

BreakingsNov 5 12:01

Wegovy Manufacturer Inks Multi-Million Deal For Monthly Obesity Drug

BenzingaNov 5 02:34